| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/06/2005 | EP1549141A2 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 07/06/2005 | EP1513486A4 Composition for enhancing oral health |
| 07/06/2005 | EP1330254B1 Treatment of cancers by aplidine in conjunction with carnitine or acetylcarnitine |
| 07/06/2005 | EP1239862B1 Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating tumor diseases |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | EP1171089B1 Skin care compositions containing combination of skin care actives |
| 07/06/2005 | EP1044001B1 Integrin receptor antagonists |
| 07/06/2005 | CN1636229A Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response |
| 07/06/2005 | CN1636070A Nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636061A Novel serine protease genes related to DPPIV |
| 07/06/2005 | CN1636020A Method for controlling angiogenesis in animals |
| 07/06/2005 | CN1636016A Methods to inhibit viral replication |
| 07/06/2005 | CN1636015A HCV e1e2 vaccine compositions |
| 07/06/2005 | CN1635923A Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 07/06/2005 | CN1635912A Targeted delivery of drugs for the treatment of parasitic infections |
| 07/06/2005 | CN1635911A Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 07/06/2005 | CN1635910A Treatment and diagnosis of macrophage mediated disease |
| 07/06/2005 | CN1635909A Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient |
| 07/06/2005 | CN1635908A Antibodies that immunospecifically bind to trail receptors |
| 07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 07/06/2005 | CN1635899A Stimulation of bone growth with thrombin peptide derivatives |
| 07/06/2005 | CN1635897A Photoprotective orally administrable composition for skin |
| 07/06/2005 | CN1635887A Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 |
| 07/06/2005 | CN1635886A Method for treating diseases with omega interferon |
| 07/06/2005 | CN1635881A Liquid formulation of metformin |
| 07/06/2005 | CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists |
| 07/06/2005 | CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/06/2005 | CN1635872A Proliposomal drug delivery system |
| 07/06/2005 | CN1635864A Oligosaccharide aldonic acids and their topical use |
| 07/06/2005 | CN1635856A Method of administering an injectable antibiotic to an animal |
| 07/06/2005 | CN1635849A Bone anti-resorptive compounds |
| 07/06/2005 | CN1634593A Carbonized pollen and its application for preparing medicine to treat cancer |
| 07/06/2005 | CN1634589A Injection using invert sugar water solution as carrier |
| 07/06/2005 | CN1634587A Compound preparation for treating urgent and chronic liver diseases and its preparation method |
| 07/06/2005 | CN1634586A Anti-cancer medicine composition |
| 07/06/2005 | CN1634585A Anti-cancer medicine composition |
| 07/06/2005 | CN1634584A Anti-cancer medicine composition containing antimetabolite |
| 07/06/2005 | CN1634583A Anti-cancer medicine composition containing antineoplastic antibiotics |
| 07/06/2005 | CN1634565A Protein medicine microcapsule and inhalational aerosol thereof |
| 07/06/2005 | CN1634133A Suspension of Fe#-[3]O#-[4] microparticle and iodized oil for treating liver and kidney tumor by embolizing and its preparation process |
| 07/06/2005 | CN1634123A Eye formulation administering system containing lecithin and sodium hyaluronic acid and its preparing method |
| 07/06/2005 | CN1634118A Antivirus formulation containing polysaccharide polyanion zinc salt and its preparing process |
| 07/06/2005 | CN1634022A Pharmaceutical composition containing isosorbide mononitrate for treating high blood pressure |
| 07/06/2005 | CN1633995A Percutaneous contraceptive drugs delivery system and method |
| 07/06/2005 | CN1633994A Compound control-released percutaneous medicine plaster for treating high blood pressure and its preparation method |
| 07/06/2005 | CN1209166C Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 07/06/2005 | CN1209164C Compositions comprising DNA damaging agents and P53 |
| 07/05/2005 | US6914122 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/05/2005 | US6914080 Amine compounds and inhibiting neurotransmitter reuptake |
| 07/05/2005 | US6914073 Multivitamin/multimineral optimized for cardiovascular health containing increased levels of Vitamin E; does not leach vitamin E |
| 07/05/2005 | US6914070 Ophthalmic compositions for treating ocular hypertension |
| 07/05/2005 | US6914055 Cancer therapeutic formulation having reduced toxicity comprising a galactomannan, and a chemotherapeutic agent |
| 07/05/2005 | US6914050 Stimulation of bone growth with thrombin peptide derivatives |
| 07/05/2005 | US6914046 Administering human growth hormone having a specific amino acid sequence to cancer patients who are resistant to, or at risk of developing a resistance to a NF-kappa B-activating cytotoxic molecule |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913883 IGF-1 receptor interacting proteins |
| 07/05/2005 | US6913764 Antibiotic(s) preparation with retarding active ingredient release |
| 07/05/2005 | US6913761 Sustained drug delivery |
| 07/05/2005 | US6913760 Polymer and a pain-relieving combination of an anesthetic agent and an analgesic agent. |
| 07/05/2005 | US6913744 Administering collagenase and other enzymes; side effect reduction |
| 07/05/2005 | US6913615 Chemiluminescent treatment of acne |
| 07/05/2005 | CA2327439C Combination therapy for the treatment of tumors |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 06/30/2005 | WO2005059172A2 Method and nucleic acids for the improved treatment of breast cell proliferative disorders |
| 06/30/2005 | WO2005059115A1 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers |
| 06/30/2005 | WO2005058883A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 06/30/2005 | WO2005058363A2 Pharmaceutical composition of a sodium channel blocker and a selective serotonin uptake inhibitor |
| 06/30/2005 | WO2005058361A1 USE OF mGluR1 ANTAGONISTS FOR THE TREATMENT OF GERD |
| 06/30/2005 | WO2005058348A1 Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic |
| 06/30/2005 | WO2005058341A2 Compositions for use in the treatment of mutant receptor tyrosine kinase driven cellular proliferative diseases |
| 06/30/2005 | WO2005058324A1 Use of siramesine in the treatment of cancer |
| 06/30/2005 | WO2005058323A1 USE OF METABOTROPIC GLUTAMATE RECEPTOR 1 (mGLuR1) ANTAGONISTS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) |
| 06/30/2005 | WO2005058322A1 USE OF METABOTROPIC GLUTAMATE RECEPTOR 1 (mGLuR1) ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS |
| 06/30/2005 | WO2005058320A1 COMBINATION OF (a) N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE AND (b) AT LEAST ONE HYPUSINATION INHIBITOR AND THE USE THEREOF |
| 06/30/2005 | WO2005058319A1 Methods and compositions |
| 06/30/2005 | WO2005058316A1 Medicinal compositions and combinations |
| 06/30/2005 | WO2005058308A2 Treatment for alzheimer's disease and related conditions |
| 06/30/2005 | WO2005058306A1 Glutamine-containing energy imparting amino acid composition or amino acid solution |
| 06/30/2005 | WO2005058295A2 Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases |
| 06/30/2005 | WO2005058288A2 Antimicrobial article with diffusion control layer |
| 06/30/2005 | WO2005058244A2 Novel anti-dc-sign antibodies |
| 06/30/2005 | WO2005058230A2 Topical use of halosalicylic acid derivatives |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2005007193A3 Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
| 06/30/2005 | WO2005000852A3 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 06/30/2005 | WO2004110392A3 Compositions and methods for treating coronavirus infection and sars |
| 06/30/2005 | WO2004018999A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2004001381A3 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143467 Adjust fatty acid oxidation; stimulant carnitine palmitoly transferase |
| 06/30/2005 | US20050143435 Drug mixture comprising Moxonidine and Eprosartan mesylate for control of blood pressure; hypotensive agents treating type II diabetes, associated with heart failure, or renal impairment; rilmenidine, and candesartan, eprosartan, irbesartan, losartan, olmesartan, pratosartan, telmisartan and valsartan |
| 06/30/2005 | US20050143424 antidiabetic mixture contains an inhibitor of renal glucose reabsorption and a hypoglycemic agent; controlling blood glucose level; tolbutamide, chlorpropamide, glibenclamide, glipizide, glimepiride, and gliclazide; metformin, phenformin and buformin; repaglinide, nateglinide and mitiglinide |
| 06/30/2005 | US20050143420 administering immunomodulatory compounds; sickle cell anemia or beta -thalassemia; 4-(Amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione; 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 06/30/2005 | US20050143412 Controlled cessation of heart beat during cardiac surgeries by electrical stimulation of the vagus nerve and administration of a combination of drugs; improved surgical technique; Controlled intermittent asystole |
| 06/30/2005 | US20050143388 Nitric oxide donors for treatment of disease and injury |
| 06/30/2005 | US20050143386 Diagnosis and management of infection caused by Chlamydia |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 06/30/2005 | US20050143368 Chemical compounds |